Article

Zyoptix XP microkeratome reported to produce predictable, more accurate LASIK flaps

Data presented at the American Academy of Ophthalmology annual meeting from the first head-to-head contralateral study comparing the outcomes of the latest Bausch & Lomb microkeratome technology against the Intralase Femtosecond (FS) device show that the new Bausch & Lomb Zyoptix XP microkeratome:

Chicago-Data presented at the American Academy of Ophthalmology annual meeting from the first head-to-head contralateral study comparing the outcomes of the latest Bausch & Lomb microkeratome technology against the Intralase Femtosecond (FS) device show that the new Bausch & Lomb Zyoptix XP microkeratome:

• Was statistically significantly more accurate with respect to intended flap thickness.

• Produced on average thinner corneal flaps with respect to intended flap thickness.

• Had a comparable standard deviation in flap thickness.

• Demonstrated equivalent uncorrected and best-corrected visual acuity under high- and low-light contrast conditions.

“The study findings strongly suggest that surgeons who use the Zyoptix XP microkeratome can expect to achieve the same level of precision, predictability, and outcomes that have been ascribed to the latest generation laser flap-creation technology,” said lead investigator Hung Ming Lee, MD.

The prospective, randomized, controlled, contralateral eye study compared flap thickness as measured by both conventional ultrasound pachymetry and advanced optical coherence pachymetry. The study results were based on 98 eyes of 49 patients.

More information is available at the Bausch & Lomb Booths 2907 and 3204.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.